Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, May 17, 2012
Technology Networks
 
Register | Sign in
Home Page
  Permissions

Permission to use, copy and distribute documents presented on this World Wide Web site and related graphics is not granted without prior written permission of Technology Networks Ltd

To obtain this permission contact:
Technology Networks Ltd
Unit 6, Woodview
Bull Lane
Acton
Sudbury
CO10 0FD, U.K.

In cases where permission is granted, it is done so under the provision that the above copyright notice and this permission notice appear in all copies. All other rights are reserved.

The information and data included in the TechnologyNetworks.com WWW site, and all its affiliated websites and associated email newsletters, have been compiled from a variety of sources, and are subject to change without notice. Technology Networks Ltd. makes no warranties or representations whatsoever regarding the quality, content, completeness, or adequacy of this information and data.

Technology Networks Ltd. specifically disclaims all warranties with respect to this WWW site, email newsletters or your use thereof, express, implied, or otherwise, including without limitation, all warranties of merchantability and fitness for a particular purpose. Technology Networks Ltd shall not be liable for any special, incidental, or consequential damages, including, without limitation, lost revenues, lost profits, or loss of prospective economic advantage, resulting from the use or misuse of this site, or the information therein.

Scientific News
Selecting IVF Embryos for Normal Numbers of Chromosomes can Significantly Increase Pregnancy Rates
First randomized prospective study shows ongoing pregnancy rate after 20 weeks per cycle started of 69.1% in the 24sure treatment group vs 41.7% in the control group.
Promise of Structure-Based Drug Design for GPCRs
Heptares Therapeutics announces the recent publication of a major review of the state of the art for GPCR drug discovery and new insights that, for the first time, can be obtained from structural biology.
New Biomarkers Could Offer Vital Clues for Cancer Research
European funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore.
Guidelines for Prostate Screening Widely Ignored, Study Finds
2008 recommendations from federal task force had no impact.
Researchers Turn Big Data Problems into Advanced Biology and Drug Discoveries
University of Illinois at Chicago and The Genome Analysis Centre in Norwich, UK leverage SGI(R) UV(TM) to accelerate drug discovery and complex problem analysis.
New Research on Zebrafish Brings a Cure for Hearing Loss Closer
Zebrafish to discover drugs that may lead to the restoration of hearing.
Completion of Alzheimer’s Plasma Biomarker Study
The preliminary results demonstrate significant diagnostic and prognostic utilities.
ERSPC Latest Findings Confirm Increased Mortality Benefit from Prostate Cancer Testing
Extended follow up needed to establish full impact of screening.
Broad Institute, Dana-Farber and Novartis Collaborate to Develop Cancer Cell Line Encyclopedia
Scientists have written the 'Book of Cancer Knowledge' to aid future research into drug discovery and personalized medicine.
Specificity Quantification of Biomolecular Recognition and its Implication for Drug Discovery
Highly efficient and specific biomolecular recognition requires both affinity and specificity. Here scientists developed a novel method SPA (SPecificity and Affinity) based on funneled energy landscape theory, with increased specificity on previous models.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net